These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 6100289

  • 21. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
    Kim MJ, Kwon OS, Chung NS, Lee SY, Jung HS, Park DK, Ku YS, Kim YK, Kim YS, Kim JH.
    Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
    [Abstract] [Full Text] [Related]

  • 22. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
    Chen DS.
    Princess Takamatsu Symp; 1995 Mar; 25():27-32. PubMed ID: 8875606
    [Abstract] [Full Text] [Related]

  • 23. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan.
    Tamori A, Nishiguchi S, Kubo S, Narimatsu T, Habu D, Takeda T, Hirohashi K, Shiomi S.
    J Med Virol; 2003 Dec; 71(4):492-8. PubMed ID: 14556260
    [Abstract] [Full Text] [Related]

  • 24. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
    Matsuzaki Y, Sato M, Saito Y, Karube M, Doy M, Shoda J, Abei M, Tanaka N, Hadama T, Kinoshita M.
    J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
    [Abstract] [Full Text] [Related]

  • 25. Hepatitis C virus, alcoholic cirrhosis, and hepatocellular carcinoma.
    Goeser T, Müller HM, Solbach C, Toex U, Kommerell B, Theilmann L.
    Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):311-5. PubMed ID: 8061579
    [Abstract] [Full Text] [Related]

  • 26. Hepatocellular carcinoma: risk factors other than HBV.
    Villa E, Melegari M, Scaglioni PP, Trande P, Cesaro P, Manenti F.
    Ital J Gastroenterol; 1991 Jun; 23(7):457-60. PubMed ID: 1660333
    [Abstract] [Full Text] [Related]

  • 27. Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China.
    Ming L, Thorgeirsson SS, Gail MH, Lu P, Harris CC, Wang N, Shao Y, Wu Z, Liu G, Wang X, Sun Z.
    Hepatology; 2002 Nov; 36(5):1214-20. PubMed ID: 12395332
    [Abstract] [Full Text] [Related]

  • 28. [Human hepatitis B virus and hepatocellular carcinoma].
    Rivkina MB, Tikhonenko TI.
    Mol Gen Mikrobiol Virusol; 1990 Feb; (2):3-9. PubMed ID: 2159110
    [Abstract] [Full Text] [Related]

  • 29. Relationship between hepatocellular carcinoma and cirrhosis.
    Kew MC, Popper H.
    Semin Liver Dis; 1984 May; 4(2):136-46. PubMed ID: 6087459
    [Abstract] [Full Text] [Related]

  • 30. [The relation of infection with the hepatitis B-agent to primary hepatic carcinoma (author's transl)].
    Blumberg BS, Larouzé B, London WT, Werner B, Hesser JE, Millman I, Saimot G, Payet M.
    Leber Magen Darm; 1976 Dec; 6(6):309-15. PubMed ID: 190499
    [Abstract] [Full Text] [Related]

  • 31. Hepatitis B virus, hepatocellular carcinoma and liver cirrhosis in Kenya.
    Mwangi J, Gatei DG.
    East Afr Med J; 1993 Apr; 70(4 Suppl):34-6. PubMed ID: 8223308
    [Abstract] [Full Text] [Related]

  • 32. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
    Adachi S, Shibuya A, Miura Y, Takeuchi A, Nakazawa T, Saigenji K.
    Scand J Gastroenterol; 2008 Apr; 43(7):849-56. PubMed ID: 18584524
    [Abstract] [Full Text] [Related]

  • 33. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
    Chiaramonte M, Stroffolini T, Vian A, Stazi MA, Floreani A, Lorenzoni U, Lobello S, Farinati F, Naccarato R.
    Cancer; 1999 May 15; 85(10):2132-7. PubMed ID: 10326690
    [Abstract] [Full Text] [Related]

  • 34. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
    Vaiphei K, Pal NS, Arora SK.
    Indian J Pathol Microbiol; 2006 Jul 15; 49(3):357-61. PubMed ID: 17001884
    [Abstract] [Full Text] [Related]

  • 35. [Expression of GST-pi and HBV infection in hepatocellular carcinoma].
    Shen LJ, Zhang ZJ, Zhang HX, Yang WB, Huang R.
    Ai Zheng; 2002 Jan 15; 21(1):29-32. PubMed ID: 12500393
    [Abstract] [Full Text] [Related]

  • 36. Geographic variation in viral load among hepatitis B carriers with differing risks of hepatocellular carcinoma.
    Evans AA, O'Connell AP, Pugh JC, Mason WS, Shen FM, Chen GC, Lin WY, Dia A, M'Boup S, Dramé B, London WT.
    Cancer Epidemiol Biomarkers Prev; 1998 Jul 15; 7(7):559-65. PubMed ID: 9681522
    [Abstract] [Full Text] [Related]

  • 37. Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan?
    Shiratori Y, Shiina S, Zhang PY, Ohno E, Okudaira T, Payawal DA, Ono-Nita SK, Imamura M, Kato N, Omata M.
    Cancer; 1997 Dec 01; 80(11):2060-7. PubMed ID: 9392327
    [Abstract] [Full Text] [Related]

  • 38. Increased risk of hepatocellular carcinoma in male hepatitis B surface antigen carriers with chronic hepatitis who have detectable urinary aflatoxin metabolite M1.
    Sun Z, Lu P, Gail MH, Pee D, Zhang Q, Ming L, Wang J, Wu Y, Liu G, Wu Y, Zhu Y.
    Hepatology; 1999 Aug 01; 30(2):379-83. PubMed ID: 10421643
    [Abstract] [Full Text] [Related]

  • 39. Hepatitis B vaccination: an important method of preventing HBV-related hepatocellular carcinoma.
    Zanetti A.
    Ital J Gastroenterol; 1992 Feb 01; 24(2):100-2. PubMed ID: 1315589
    [Abstract] [Full Text] [Related]

  • 40. Association of hepatitis C virus and hepatocellular carcinoma in the United States.
    Reid AE, Liang TJ.
    Princess Takamatsu Symp; 1995 Feb 01; 25():41-9. PubMed ID: 8875608
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.